Thompson Davis & CO. Inc. acquired a new position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 22,775 shares of the company's stock, valued at approximately $494,000. Thompson Davis & CO. Inc. owned 0.45% of Nutex Health as of its most recent filing with the Securities and Exchange Commission.
Separately, Essex Investment Management Co. LLC bought a new stake in Nutex Health in the 3rd quarter valued at $1,579,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Nutex Health news, CFO Jon Christian Bates bought 1,350 shares of the stock in a transaction dated Thursday, August 22nd. The stock was bought at an average cost of $21.46 per share, for a total transaction of $28,971.00. Following the completion of the purchase, the chief financial officer now owns 2,277 shares in the company, valued at $48,864.42. This represents a 145.63 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 38.52% of the company's stock.
Nutex Health Price Performance
Shares of Nutex Health stock traded up $1.32 during mid-day trading on Wednesday, reaching $30.10. 13,518 shares of the stock were exchanged, compared to its average volume of 42,660. Nutex Health Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $39.48. The company has a market cap of $163.65 million, a price-to-earnings ratio of -3.26 and a beta of 0.11. The firm has a 50-day simple moving average of $23.82 and a 200 day simple moving average of $14.65. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36.
Analyst Ratings Changes
A number of research firms have recently commented on NUTX. Benchmark raised their price objective on shares of Nutex Health from $45.00 to $60.00 and gave the stock a "buy" rating in a report on Tuesday, November 12th. Maxim Group lifted their price objective on Nutex Health from $45.00 to $50.00 and gave the company a "buy" rating in a report on Tuesday, November 12th.
View Our Latest Stock Analysis on NUTX
Nutex Health Profile
(
Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
See Also
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
